PCRX · Categories · Upgrades
PCRX - Analyst upgrades
Pacira BioSciences Inc. (PCRX) analyst upgrades - real-time wire coverage filtered to Upgrades only.
Recent Upgrades for PCRX
- Pacira BioSciences upgraded by Truist with a new price targetTruist upgraded Pacira BioSciences from Hold to Buy and set a new price target of $30.00
- Pacira BioSciences upgraded by Truist with a new price targetTruist upgraded Pacira BioSciences from Sell to Hold and set a new price target of $25.00 from $8.00 previously
- Pacira BioSciences upgraded by TD Cowen with a new price targetTD Cowen upgraded Pacira BioSciences from Market Perform to Outperform and set a new price target of $50.00
- Pacira BioSciences upgraded by JP Morgan with a new price targetJP Morgan upgraded Pacira BioSciences from Neutral to Overweight and set a new price target of $75.00